Portage Biotech announced the re-launch of its subsidiary, Cyncado Therapeutics, which will focus on developing adenosine receptor antagonists. Peter Molloy has been appointed CEO of Cyncado to lead its clinical development efforts.
Company Information
Company
Portage Biotech
Location
Clarence Thomas Building, PO Box 4649
Road Town, Virgin Islands, British
About
Portage Biotech is clinical stage biopharmaceutical company driving the development of first-in-class immuno-oncology therapies to help more patients achieve durable treatment responses and a better quality of life. The Company is using its strong industry network and diverse drug platforms to identify novel assets and asset combinations.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Portage Biotech ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.